Home /
The largest and most established orphan drug & rare disease meeting – The World Orphan Drug Congress – will be held on 27 – 29 October, at RAI Congress Centre in Amsterdam. EPTRI will present a poster during the Congress to showcase EPTRI Thematic Research...
Our president, Karel Allegaert, participated in the paediatric committee (PDCO) scientific meeting related to the Belgian presidency that was held last week in Leuven. Related to the ongoing revision of the EMA guideline on neonatal clinical studies, Karel discussed...
Donato Bonifazi and Adriana Ceci, both members of our Board of Directors, have co-authored the research paper entitled: “Innovative research methodologies in the EU regulatory framework: an analysis of EMA qualification procedures from a pediatric perspective”,...
We are very happy to announce that incorporated in the form of an Association International Sans But Lucrative (AISBL). The approval was granted by the Belgium Government as EPTRI is based in Leuven. This means that EPTRI can now apply to grants and other funding as...
We are excited to announce that the proposal OrphaDev4Kids has been approved. This collaborative project aims to address the issue of Orphan medical devices (MDs) to be used in the paediatric population. Paediatric MDs development is more complex and riskier for...
EPTRI supports the joint statement on Hospital Exemption. The signatories of this statement are key stakeholders in the healthcare ecosystem at both the European Union and Member State level comprising of health care professionals’ associations, patient organisations...